Study: Myo-inositol may lower gestational diabetes risk

01/31/2013 | Reuters

Taking myo-inositol supplements may reduce the likelihood of gestational diabetes among pregnant women at risk for the condition, according to a small study in Diabetes Care. Data on 220 pregnant women with a family history of type 2 diabetes showed 6% of those who took myo-inositol supplements in addition to folic acid developed gestational diabetes, compared with 15% of those only given folic acid.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD